B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: What is the clinical significance?

Clinical Rheumatology

Volumn 26, Issue 10, 2007, Pages 1701-1704

  Karadag, Omer ^a   Calguneri, Meral ^a   Yavuz, Bunyamin ^a   Atalar, Enver ^a   Akdogan, Ali ^a   Kalyoncu, Umut ^a   Kiraz, Sedat ^a   Aksoyek, Serdar ^a   Ozmen, Ferhan ^a   Ertenli, A Ihsan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

B type natriuretic peptide (BNP); Cardiovascular diseases; Diastolic dysfunction; Novel cardiovascular risk factors; Systemic lupus erythematosus (SLE)

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; LIPID;

AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ACTIVITY; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM; HEART EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING HABIT; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY; ADULT; AGE; BLOOD; CARDIOVASCULAR DISEASE; INFLAMMATION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MODELS, STATISTICAL; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548845365     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0575-4     Document Type: Article

References (21)

1. J Wajed, et al. 2004 Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management Rheumatology 43 1 7 12 12867578 10.1093/rheumatology/keg436 1:STN:280:DC%2BD3sngtVSltg%3D%3D (Pubitemid 38088360)
2. DP D'Cruz 2006 Systemic lupus erythematosus BMJ 332 7546 890 894 16613963 10.1136/bmj.332.7546.890
3. JE Salmon MJ Roman 2001 Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management Curr Opin Rheumatol 13 5 341 344 11604586 10.1097/00002281-200109000-00001 1:STN:280:DC%2BD3Mrls1ygsA%3D%3D (Pubitemid 32929861)
4. M Weber C Hamm 2006 Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine Heart 92 6 843 849 16698841 10.1136/hrt.2005. 071233 1:CAS:528:DC%2BD28XlvVSktrg%3D (Pubitemid 43799232)
5. TJ Wang, et al. 2004 Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 7 655 663 14960742 10.1056/NEJMoa031994 1:CAS:528:DC%2BD2cXhtFCrtrg%3D (Pubitemid 38364624)
6. SM Harney, et al. 2006 Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis Ann Rheum Dis 65 1 136 16344502 10.1136/ard.2005.040634 1:STN:280:DC%2BD2MnmtFCmtQ%3D%3D (Pubitemid 41815659)
7. EM Tan, et al. 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 11 1271 1277 7138600 10.1002/art.1780251101 1:STN:280:DyaL3s%2FkvVCmtA%3D%3D (Pubitemid 13221242)
8. DD Gladman D Ibanez MB Urowitz 2002 Systemic lupus erythematosus disease activity index 2000 J Rheumatol 29 2 288 291 11838846
9. S Kalke, et al. 1998 Echocardiography in systemic lupus erythematosus Lupus 7 8 540 544 9863896 10.1191/096120398678920578 1:STN:280: DyaK1M%2FnvFKjsg%3D%3D
10. E Toubi, et al. 2000 The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients Lupus 9 2 92 95 10787004 10.1191/096120300678828082 1:CAS:528:DC%2BD3cXjt1Cktbw%3D
11. Q Dao, et al. 2001 Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J Am Coll Cardiol 37 2 379 385 11216950 10.1016/S0735-1097(00)01156-6 1:CAS:528:DC%2BD3MXhsl2jt7Y%3D
12. E Lubien, et al. 2002 Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 5 595 601 11827925 10.1161/hc0502.103010 1:CAS:528:DC%2BD38XhslGgs78%3D (Pubitemid 34123434)
13. PA McCullough 2004 B-type natriuretic peptide and its clinical implications in heart failure Am Heart Hosp J 2 1 26 33 15604836 10.1111/j.1541-9215.2004.03312.x
14. P Uusimaa, et al. 2004 Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension Int J Cardiol 97 2 251 256 15458692 10.1016/j.ijcard.2003.10.015 (Pubitemid 39286844)
15. MA Bhalla, et al. 2004 Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus J Am Coll Cardiol 44 5 1047 1052 15337217 10.1016/j.jacc.2004.05.071 1:CAS:528:DC%2BD2cXntVOhtL0%3D (Pubitemid 39165140)
16. Z Sasson, et al. 1992 Impairment of left ventricular diastolic function in systemic lupus erythematosus Am J Cardiol 69 19 1629 1634 1598881 10.1016/0002-9149(92)90715-B 1:STN:280:DyaK383os1antw%3D%3D
17. S Fujimoto, et al. 1994 Doppler echocardiographic assessment of left ventricular diastolic function in patients with systemic lupus erythematosus Cardiology 85 3-4 267 272 7987885 1:STN:280:DyaK2M%2FnvFCksw%3D%3D 10.1159/000176685
18. Y Murakami, et al. 2002 New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy Can J Cardiol 18 12 1294 1300 12518181 1:CAS:528: DC%2BD3sXot1CrtQ%3D%3D
19. O Schillaci, et al. 1999 Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus Eur J Nucl Med 26 7 713 717 10398819 10.1007/s002590050442 1:STN:280:DyaK1MzivVyrsA%3D%3D (Pubitemid 29338659)
20. BS Rana, et al. 2006 B-type Natriuretic Peptide can detect silent myocardial ischaemia in asymptomatic type II diabetic patients Heart 92 916 920 16339811 10.1136/hrt.2005.071423 1:CAS:528:DC%2BD28Xntl2ltLw%3D (Pubitemid 43974053)
21. WE Hopkins, et al. 2004 Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion Circulation 109 23 2872 2877 15173030 10.1161/01.CIR.0000129305.25115.80 1:CAS:528: DC%2BD2cXksF2lurY%3D (Pubitemid 38780301)